Sep 16
Current report
8-K
Events of Sep 15
Charter or bylaw amendment, or fiscal year change
AI summary on its way
MDTK · Bryn Inc.
$2,100.00
At close · Sep 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the Company does not expect that existing operational cash flow will be sufficient to fund presently anticipated operations, this raises substantial doubt about the Company's ability to continue as a going concern for the twelve months following the issuance of these financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$9.45M
Shares
4,500
Volume · Sep 23
1
Avg daily vol (1 sessions)
—
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2,100.00
Open$4,800.00
Day$370.00–36,330.00
Available close range$2,100.00–2,100.00
Avg vol available · 1d1
DataSep 2026–Sep 2026
Filing10-Q · Aug 14
The closing range uses available history since Sep 23, 2026; less than a full year is stored.
Latest documents
2026
Aug 14
Quarterly report
10-Q
FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2
AI summary on its way
Net loss $178.65K
Diluted EPS $0.00
May 19
Quarterly report
10-Q
FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1
AI summary on its way
Net loss $30.94K
Diluted EPS $0.00
May 11
Current report
8-K
Events of Apr 24
Change in control, Director or officer change, or executive pay
AI summary on its way
May 11
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$21,000
Trailing 12 months
Net income (TTM)
−$224,726
Trailing 12 months
Revenue growth YoY
+144.9%
Year over year
Operating margin
-5,587.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
—
Trailing year
Short interest
—
Latest settlement
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Limited
Momentum
Limited
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Limited
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.72
Technical
price trend
Not enough data for a confident read.
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
No short-interest data
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Not enough data for a confident read.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
No short-interest data
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its available closing range
Price range unavailable — no recent comparable closes.
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MDTK
this stock
Bryn Inc.
|
$9.45M | — | — | — | 0.0% |
|
VYLR
Vylor Inc.
|
$48.09B | — | — | — | 2.1% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$652.61M | +3.5% | — | — | 0.0% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$606.10M | +3.4% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MDTK | — | — | — | — | — |
| SPY | +1.8% | +0.3% | +17.2% | +0.1% | +12.6% |
| vs SPY | — | — | — | — | — |
Key facts
CIK
1397795